Breast cancer medication added to PBS

A new drug has been added to the Pharmaceutical Benefits Scheme which can help stop breast cancer from spreading. Abemaciclib works by blocking specific overactive proteins which signal cancer cells to grow. Breast cancer is the most common cancer among women. Reportedly, an average of 57 cases are diagnosed every day. “This particular medication for the purpose it’s approved and the type of breast cancer it’s approved, we estimate will be suitable for up to 1,800 Australian patients every year,” Peter MacCallum Centre Associate Professor Shom Goel told Sky News Australia.